1. Home
  2. MYNZ vs ADXN Comparison

MYNZ vs ADXN Comparison

Compare MYNZ & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • ADXN
  • Stock Information
  • Founded
  • MYNZ 2021
  • ADXN 2002
  • Country
  • MYNZ Germany
  • ADXN Switzerland
  • Employees
  • MYNZ N/A
  • ADXN N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYNZ Health Care
  • ADXN Health Care
  • Exchange
  • MYNZ Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • MYNZ N/A
  • ADXN 11.3M
  • IPO Year
  • MYNZ 2021
  • ADXN N/A
  • Fundamental
  • Price
  • MYNZ $0.31
  • ADXN $11.26
  • Analyst Decision
  • MYNZ Buy
  • ADXN Strong Buy
  • Analyst Count
  • MYNZ 2
  • ADXN 1
  • Target Price
  • MYNZ $3.00
  • ADXN $30.00
  • AVG Volume (30 Days)
  • MYNZ 2.3M
  • ADXN 24.7K
  • Earning Date
  • MYNZ 11-14-2024
  • ADXN 11-11-2024
  • Dividend Yield
  • MYNZ N/A
  • ADXN N/A
  • EPS Growth
  • MYNZ N/A
  • ADXN N/A
  • EPS
  • MYNZ N/A
  • ADXN 0.05
  • Revenue
  • MYNZ $917,203.00
  • ADXN $960,641.00
  • Revenue This Year
  • MYNZ $36.69
  • ADXN N/A
  • Revenue Next Year
  • MYNZ $91.67
  • ADXN N/A
  • P/E Ratio
  • MYNZ N/A
  • ADXN $1.87
  • Revenue Growth
  • MYNZ 16.23
  • ADXN N/A
  • 52 Week Low
  • MYNZ $0.19
  • ADXN $5.00
  • 52 Week High
  • MYNZ $3.39
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 51.63
  • ADXN 64.36
  • Support Level
  • MYNZ $0.28
  • ADXN $10.04
  • Resistance Level
  • MYNZ $0.33
  • ADXN $10.81
  • Average True Range (ATR)
  • MYNZ 0.05
  • ADXN 0.63
  • MACD
  • MYNZ 0.00
  • ADXN 0.08
  • Stochastic Oscillator
  • MYNZ 42.69
  • ADXN 86.17

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: